Functional Recovery after Scutellarin Treatment in Transient Cerebral Ischemic Rats: A Pilot Study with ¹⁸F-Fluorodeoxyglucose MicroPET

Table 4

The expression of NVU immunoreactive (mean ± SEM, numbers of positive cells/field of vision).

Group	𝑛	vWF	GFAP	NeuN
Sham group	3	7.33±2.51	2222.24±481.44	46.67±8.74
CIRU group	3	11.33^∗±2.52	2936.06±703.33	47.67±8.14
Scu-50 group	3	13.0^∗±1.00	3438.27^∗±805.82	75.00^∗∗,w,∗∗∗±6.08
Scu-25 group	3	10.0^∗±1.00	3509.09^∗±281.83	48.33±5.51
Nimodipine group	3	14.0^∗±1.73	3016.93±113.45	59.67±8.33

Values are means ± SD.
^∗𝑃<0.05; significantly lower compared with values of sham group.
^∗∗𝑃<0.01; significantly higher compared with values of Scu-25 group.
^∗∗∗𝑃<0.001; significantly higher compared with values of CIRU group.
^w𝑃<0.05; significantly higher compared with values of nimodipine group.